Ddo-2213

Ddo-2213

AOB12334

1000 Items

$0.00

Overview

Novel Potent and Orally Bioavailable Inhibitor of the WDR5-Mixed Lineage Leukemia 1 (MLL1) Protein-Protein Interaction for the Treatment of MLL Fusion Leukemia